Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
N. Engl. j. med; 384 (11), 2021
BACKGROUND—Whether a broadly neutralizing antibody (bnAb) can be used to prevent human immunodeficiency virus type 1 (HIV-1) acquisition is unclear. METHODS—We enrolled at-risk cisgender men and transgender persons in the Americas and Europe in the HVTN 704/HPTN 085 trial and at-risk women in sub-Sah...